|
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 229.98 USD | -6.13% |
|
-18.39% | +164.59% |
| 06-30 | Benchmark Adjusts Price Target on Dave to $320 From $229, Maintains Buy Rating | MT |
| 06-30 | Dave Inc.(NasdaqGM:DAVE) added to Russell 2000 Growth-Defensive Index | CI |
| Capitalization | 2.69B 2.3B 2.14B 2B 3.69B 231B 4.09B 25.72B 9.81B 108B 10.1B 9.89B 397B | P/E ratio 2025 * |
32.1x | P/E ratio 2026 * | 25.2x |
|---|---|---|---|---|---|
| Enterprise value | 2.69B 2.3B 2.14B 2B 3.69B 231B 4.09B 25.72B 9.81B 108B 10.1B 9.89B 397B | EV / Sales 2025 * |
5.75x | EV / Sales 2026 * | 4.86x |
| Free-Float |
73.14% | Yield 2025 * |
-
| Yield 2026 * | - |
More valuation ratios
* Estimated data
More news
Last Transcript: Dave Inc.
More recommendations
More press releases
| Beursnieuweling Onward Medical boekt verlies | 26/04/22 | |
| Wall Street sluit hoger | 29/03/22 | |
| Wall Street op winst | 29/03/22 | |
| Wall Street richting hogere opening | 29/03/22 | |
| Futures voorspellen hogere opening Wall Street | 29/03/22 |
| 1 day | -6.13% | ||
| 1 week | -18.39% | ||
| Current month | -14.32% | ||
| 1 month | -0.73% | ||
| 3 months | +176.98% | ||
| 6 months | +171.01% | ||
| Current year | +164.59% |
| 1 week | 196.32 |  | 286.45 |
| 1 month | 186.2 | | 286.45 |
| Current year | 65.46 | | 286.45 |
| 1 year | 28.74 | | 286.45 |
| 3 years | 4.47 | | 286.45 |
| 5 years | 4.47 | | 491.07 |
| 10 years | 4.47 | | 491.07 |
| Manager | Title | Age | Since |
|---|---|---|---|
Jason Wilk
CEO | Chief Executive Officer | 39 | 30/04/2016 |
Kyle Beilman
DFI | Director of Finance/CFO | 37 | 04/01/2022 |
Jessica Vaughan
COO | Chief Operating Officer | - | 29/02/2020 |
| Director | Title | Age | Since |
|---|---|---|---|
Jason Wilk
CHM | Chairman | 39 | 30/09/2015 |
Brendan Carroll
BRD | Director/Board Member | 47 | 04/01/2022 |
Dan Preston
BRD | Director/Board Member | 39 | 04/01/2022 |
| Change | 5d. change | 1-year change | 3-years change | Capi.($) | ||
|---|---|---|---|---|---|---|
| -6.13% | -18.39% | +532.86% | +1,085.56% | 2.69B | ||
| 0.00% | -4.19% | +18.83% | +85.79% | 209B | ||
| -0.36% | +4.17% | +346.19% | +1,079.14% | 86.78B | ||
| +0.53% | +0.07% | +34.64% | +4.10% | 55.95B | ||
| -7.67% | -0.76% | - | - | 42.64B | ||
| -1.96% | -3.82% | +4.06% | -16.30% | 41.17B | ||
| +4.45% | +6.50% | +189.77% | +219.42% | 21.54B | ||
| +4.53% | +23.15% | +118.01% | +220.35% | 20.88B | ||
| -5.58% | -6.46% | +118.57% | +202.85% | 20.88B | ||
| -2.28% | -3.75% | -37.78% | +87.29% | 15.54B | ||
| Average | -1.45% | -0.49% | +147.24% | +329.80% | 51.67B | |
| Weighted average by Cap. | -0.75% | -0.78% | +96.93% | +272.00% |
| 2025 * | 2026 * | |
|---|---|---|
| Net sales | 468M 401M 373M 347M 641M 40.16B 712M 4.47B 1.71B 18.8B 1.76B 1.72B 69.01B | 554M 474M 441M 411M 758M 47.52B 842M 5.29B 2.02B 22.25B 2.08B 2.03B 81.65B |
| Net income | 92.33M 79M 73.51M 68.47M 126M 7.92B 140M 882M 336M 3.71B 346M 339M 13.61B | 118M 101M 93.81M 87.38M 161M 10.11B 179M 1.13B 429M 4.73B 442M 433M 17.37B |
| Net Debt | - | - |
More financial data
* Estimated data
Employees
274
Calendar
| Date | Price | Change | Volume |
|---|---|---|---|
| 11/07/25 | 202.66 $ | -11.88% | 976,970 |
| 10/07/25 | 229.98 $ | -6.13% | 605,302 |
| 09/07/25 | 244.99 $ | -6.52% | 589,354 |
| 08/07/25 | 262.07 $ | -6.34% | 540,936 |
| 07/07/25 | 279.80 $ | -0.71% | 361,300 |
End-of-day quote Nasdaq, July 09, 2025
More quotes
Sell
Buy
Mean consensus
BUY
Number of Analysts
8
Last Close Price
202.66USD
Average target price
226.00USD
Spread / Average Target
+11.52%
Quarterly revenue - Rate of surprise
- Stock Market
- Equities
- DAVE Stock
Select your edition
All financial news and data tailored to specific country editions
MarketScreener is also available in this country: United States.
Switch edition
Stay in the current country edition